Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Moodys
Express Scripts
UBS
McKesson
Covington
Deloitte
US Army
Cipla

Generated: August 17, 2017

DrugPatentWatch Database Preview

Luliconazole - Generic Drug Details

« Back to Dashboard

What are the generic sources for luliconazole and what is the scope of luliconazole freedom to operate?

Luliconazole
is the generic ingredient in one branded drug marketed by Medicis and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Luliconazole has sixty-two patent family members in twenty-five countries.

There are five drug master file entries for luliconazole. One supplier is listed for this compound.

Summary for Generic Name: luliconazole

Tradenames:1
Patents:5
Applicants:1
NDAs:1
Drug Master File Entries: see list5
Suppliers / Packagers: see list1
Bulk Api Vendors: see list30
Clinical Trials: see list6
Patent Applications: see list32
Drug Prices:see low prices
DailyMed Link:luliconazole at DailyMed

Pharmacology for Ingredient: luliconazole

Ingredient-typeAzoles
Drug ClassAzole Antifungal
Mechanism of ActionCytochrome P450 2C19 Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis
LUZU
luliconazole
CREAM;TOPICAL204153-001Nov 14, 2013RXYesYes► Subscribe► Subscribe► Subscribe
Medicis
LUZU
luliconazole
CREAM;TOPICAL204153-001Nov 14, 2013RXYesYes► Subscribe► SubscribeYY ► Subscribe
Medicis
LUZU
luliconazole
CREAM;TOPICAL204153-001Nov 14, 2013RXYesYes► Subscribe► SubscribeY ► Subscribe
Medicis
LUZU
luliconazole
CREAM;TOPICAL204153-001Nov 14, 2013RXYesYes► Subscribe► SubscribeYY ► Subscribe
Medicis
LUZU
luliconazole
CREAM;TOPICAL204153-001Nov 14, 2013RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: luliconazole

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,085,554Method of evaluating pharmaceutical preparation containing luliconazole and index substance► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: luliconazole

Country Document Number Estimated Expiration
Denmark176599► Subscribe
Hong Kong1009751► Subscribe
Germany19681478► Subscribe
Austria407832► Subscribe
Japan5698395► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Moodys
Chubb
McKesson
Accenture
Johnson and Johnson
Express Scripts
Chinese Patent Office
US Department of Justice
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot